Admission Plan for Subdural Hematoma
All patients with subdural hematoma require hospital admission, with ICU-level monitoring indicated for acute SDH >10mm thickness or >5mm midline shift, GCS <9, coagulopathy, or any SDH requiring surgical intervention 1, 2.
Initial Assessment and Stabilization
Upon admission, immediately obtain:
- Head CT to quantify hematoma size, thickness, and midline shift
- Laboratory workup: PT, PTT, INR, platelet count 3
- Glasgow Coma Scale (GCS) score
- Neurological examination focusing on pupillary response and motor function
If the patient is comatose (GCS <9) with severe TBI:
- Control airway immediately via tracheal intubation with mechanical ventilation
- Monitor end-tidal CO2 continuously to maintain normocapnia and avoid cerebral ischemia from hypocapnia 1
- Correct any secondary brain insults
Triage Algorithm Based on SDH Characteristics
ICU Admission Required:
Acute SDH with surgical indications 1, 2:
- Thickness >5mm AND midline shift >5mm
- Any thickness if GCS <9
- GCS drop ≥2 points from injury to admission
- Asymmetric or fixed dilated pupils
- ICP >20 mmHg
Large SDH (>10 cm³ volume) - these patients demonstrate poor clinical courses and require intensive monitoring 4
Coagulopathy present - 5-fold increased risk of critical care interventions 5
Multiple intracranial hemorrhages in addition to SDH 4
Step-Down/Monitored Floor Admission Acceptable:
- Small isolated traumatic SDH (<10 cm³ volume) with:
- GCS 13-15
- No coagulopathy
- No additional intracranial hemorrhages
- Neurologically and medically stable 4
Important caveat: Isolated antiplatelet use alone is NOT a predictor of need for ICU admission and should not be used as sole criterion for ICU triage 5. However, anticoagulation or documented coagulopathy requires ICU-level care.
Immediate Neurosurgical Consultation
Obtain urgent neurosurgical evaluation for:
- Any acute SDH with thickness >10mm or midline shift >5mm (regardless of GCS) 2
- Comatose patients (GCS <9) with any SDH 2
- Rapidly deteriorating neurological exam 6
- Unilaterally or bilaterally dilated nonreactive pupils 6
- Extensor posturing 6
Coagulopathy Management
Reverse immediately if present 3:
- Warfarin: Vitamin K + prothrombin complex concentrate (PCC) or fresh frozen plasma
- Direct oral anticoagulants: Specific reversal agents (idarucizumab for dabigatran, andexanet alfa for factor Xa inhibitors)
- Thrombocytopenia: Platelet transfusion to achieve count >50,000-75,000/μL for surgery 7
ICP Monitoring
Place ICP monitor in 1:
- All comatose patients (GCS <9) with acute SDH
- Patients with refractory intracranial hypertension despite sedation
If ICP remains elevated despite first-line treatment, consider external ventricular drainage 1.
Conservative Management Protocol (Non-surgical Cases)
For small SDH not meeting surgical criteria:
- Neurological checks every 1-2 hours initially, then every 4 hours if stable
- Serial CT imaging: Repeat at 24 hours if GCS remains <15, or sooner if neurological deterioration 8
- Seizure prophylaxis: Consider in acute phase (institutional variation)
- Avoid routine repeat CT if initial CT negative and patient neurologically stable - risk of delayed complications is very low (0.04-0.3%) 8
Common Pitfalls to Avoid
- Do not discharge patients with SDH on initial CT, even if small - admission for observation is mandatory
- Do not assume all anticoagulated patients need ICU - isolated antiplatelet therapy alone does not predict need for critical interventions 5
- Do not delay coagulopathy reversal - this is time-critical to prevent hematoma expansion
- Do not perform routine repeat CT in stable patients with negative initial scan - very low yield and unnecessary radiation 8
- Do not use burr holes for acute SDH - craniotomy with or without craniectomy is the appropriate surgical approach 2, 6